A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Clinical trial NCT07331155 · RECRUITING
Trial details
- NCT number
- NCT07331155
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-26
- Primary completion
- 2028-12-26
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.